Clinical Features of Long COVID Patients Coinfected With Mycoplasma pneumoniae

Xiaodan Zhu1, Yanhua Li2, Jinghua Wang1

  • 1Department of General Practice, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310000, China.

Insights

Long COVID patients with Mycoplasma pneumoniae coinfection are more often female and show typical chest CT scans. This finding highlights a specific demographic and imaging pattern for this rare coinfection.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Public Health

Background:

  • Long COVID, a post-SARS-CoV-2 syndrome, presents prolonged health complications.
  • Mycoplasma pneumoniae is a frequent respiratory pathogen.
  • Simultaneous long COVID and Mycoplasma pneumoniae infections are infrequently documented.

Purpose of the Study:

  • To investigate the clinical characteristics of patients with coexisting long COVID and Mycoplasma pneumoniae infection.
  • To compare coinfected patients with those having long COVID alone.

Main Methods:

  • Retrospective analysis of clinical data from long COVID patients.
  • Inclusion of laboratory and radiographic findings.
  • Statistical comparison using Pearson's chi-squared test.

Main Results:

  • Fifty-two patients had long COVID with Mycoplasma pneumoniae coinfection; 77 had long COVID only.
  • No significant differences in age, symptoms, or comorbidities between groups.
  • Significant differences observed in sex distribution and chest imaging findings.

Conclusions:

  • Long COVID-Mycoplasma pneumoniae coinfection is more prevalent in females.
  • Typical chest computed tomography (CT) findings are associated with this coinfection.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
214
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
231
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
156
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
208
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K